Filter
2032
Filtered Results: 2032
Text search:
anti-microbial
Featured
Recommendations
231
New Publications
428
Language
Document type
No document type
665
Guidelines
453
Studies & Reports
427
Manuals
123
Strategic & Response Plan
113
Fact sheets
102
Online Courses
32
Training Material
31
Resource Platforms
20
Situation Updates
19
Infographics
18
Videos
16
Brochures
12
Dashboards/Maps
1
Countries / Regions
Global
90
India
89
Kenya
47
Africa
46
Latin America and the Carribbean
45
South Africa
44
Western and Central Europe
36
Ethiopia
34
Nepal
24
Brazil
23
Nigeria
21
Sierra Leone
20
Tanzania
19
Paraguay
19
Uganda
16
Ghana
15
Philippines
13
South–East Asia Region
13
Bolivia
13
Eastern Europe
13
Russia
13
Liberia
13
Malawi
12
Argentina
12
Bangladesh
12
Indonesia
12
Rwanda
11
Mozambique
11
Asia
11
Colombia
9
Cameroon
9
Germany
9
Western Pacific Region
9
Ukraine
8
Chile
8
Peru
8
Zimbabwe
8
West and Central Africa
8
Eastern Europe and Central Asia
8
Venezuela
7
East and Southern Africa
7
Namibia
7
Lesotho
6
Congo, Democratic Republic of
6
Vietnam
6
Zambia
6
Myanmar / Burma
6
Syria
5
Middle East and North Africa
5
Spain
5
Angola
5
Thailand
4
China
4
Senegal
4
Burkina Faso
4
Haiti
4
Cambodia
4
France
4
South Sudan
4
Eswatini/ Swaziland
4
Pakistan
4
Tajikistan
3
El Salvador
3
USA
3
Uruguay
3
Mali
3
Botswana
3
Ecuador
3
North Macedonia
2
Serbia
2
Laos
2
Morocco
2
Guinea
2
Guinea-Bissau
2
Jordan
2
Gabon
2
Japan
2
Sri Lanka
2
Georgia
2
Honduras
2
Iraq
2
Madagascar
2
Timor Leste/ East Timor
1
Mexico
1
Benin
1
Kazakhstan
1
Iran
1
Albania
1
Fiji
1
Kyrgyzstan
1
Congo-Brazzaville
1
Niger
1
Uzbekistan
1
Afghanistan
1
Malaysia
1
Mongolia
1
Qatar
1
Armenia
1
Ireland
1
Saudi Arabia
1
North America
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
Tunisia
1
United Kingdom
1
Portugal
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Papua New Guinea
1
Nicaragua
1
Egypt
1
Sudan
1
Yemen
1
Libya
1
Bhutan
1
Somalia
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
578
Clinical Guidelines
180
Key Resources
128
Public Health
84
Women & Child Health
60
Pharmacy & Technologies
38
Capacity Building
25
Annual Report MEDBOX
3
Toolboxes
AMR
582
COVID-19
181
TB
162
Planetary Health
101
HIV
90
NTDs
87
Pharmacy
83
Rapid Response
82
Caregiver
74
Global Health Education
39
Ebola & Marburg
37
Cholera
32
Health Financing Toolbox
31
NCDs
22
Refugee
20
Mental Health
14
Conflict
13
Polio
9
Natural Hazards
8
Specific Hazards
6
Disability
4
Zika
4
Social Ethics
1
The WHO CIA List should be used as a reference to help formulate and prioritize risk assessment and risk management strategies for containing antimicrobial resistance. The WHO CIA List supports strategies to mitigate the human health risks associated with antimicrobial use in ...
As a public good, antimicrobial medicines require rational use if their effectiveness is to be preserved. However, up to 50% of antibiotic use is inappropriate, adding considerable costs to patient care, and increasing morbidity and mortality. In addition, there is compelling evidence that antimicro...
Responding to Outbreaks of Antimicrobial-resistant Pathogens in Health-care Facilities: Guidance for the Western Pacific Region is developed following requests from Member States in the Western Pacific Region for additional information and support in managing AMR outbreaks. It aims to provide: a ste...
The purpose of this guidance is to assist WHO Member States, and other stakeholders, in the establishment and development of programmes of integrated surveillance of antimicrobial resistance in foodborne bacteria (i.e., bacteria commonly transmitted by food). In this guidance, “integrated surveill...
The spread of antimicrobial-resistant microorganisms poses anincreasing threat to affordable modern health care. In the Netherlands, efforts to control the dispersal of known and novel antimicrobial-resistant organisms have been mostly implemented at the hospital level. However, recent studies have ...
The OIE has been working on the AMR issue for a long
time. In undertaking its role as a standard- setting organisation*
for animal health, including zoonoses, the OIE has developed
a wide range of international standards on antimicrobial
agents, in particular on responsible and prudent use.
The...
Prevention, early diagnosis, and effective treatment are essential for the control and elimination of Neisseria gonorrhoeae as a public health problem. Currently, in Latin America and the Caribbean, treatment for gonorrhea infection is largely empiric and based on clinical diagnosis. In the Americas...
Nosocomial infections and antimicrobial resistance are two special health issues listed in Annex 1 of Commission Decision 2000/96/EC of 22 December 1999 on the communicable diseases to be progressively covered by the Community network under Decision No 2119/98/EC of the European Parliament and of th...
This situation analysis has gathered information about the current state of AMR, contributing factors and antimicrobial use in Zimbabwe from the human, animal, agricultural and environmental sectors. Data has been gathered from different sectors such as the general public, academia, the Ministry of ...
The National Department of Health and Department of Agriculture, Forestry and Fisheries have collectively engaged to determine the key interventions that will form the basis for this strategy taking into account the recommendations from the WHO and OIE.
The development and implementation of a Natio...
The Transatlantic Task Force on Antimicrobial Resistance (TATFAR) fosters cooperation between the European Union (EU) andthe United States (US) on the issue of antimicrobial resistance. The first TATFAR recommendation refers to appropriate use of antimicrobials in human medicine through hospital Ant...
The objectives of NAP are aligned with the global action plan based on national needs and priorities. The emphasis is on One Health approach with all sectors especially human health, animal health and environment contributing towards minimizing the emergence and impact of AMR in Jordan.
WHO CIA list categorizes all antimicrobials used in human medicine into 3 groups based on their importance to human medicine. The current scope is limited to antibacterial drugs of which most are also used in veterinary medicine. The list assists in man...
This Tailoring Antimicrobial Resistance Programmes (TAP) process assists Member States in initiating and undertaking projects to address the spread of antimicrobial resistance (AMR) in their countries. AMR is a complex problem requiring unique, context-specific solutions. This TAP Toolbo...
5th revised edition.
This document provides a ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. The current revision took place at the seventh meeting of the AGISAR held in Raleigh, United States of America in 2016.
Reports of antimicrobial-resistant (AMR) microorganisms are increasing globally, threatening to render existing treatments ineffective against many infectious diseases. In Africa, AMR has already been documented to be a problem for human immunodeficiency virus (HIV) and the pathogens that cause mala...
